Abstract
Severe acute heart failure (AHF) patients are class IV patients hospitalized due to dyspnea on worsening chronic heart failure or for acute new-onset heart failure with signs and symptoms of severe lung congestion with pulmonary edema, low output syndrome, or cardiogenic shock. It is characterized at the emergency department as heavy dyspnea, with SpO2 less than 90%, and with physical and psychological stress.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Suggested Readings
Assist Devices and Minipumps
Henriques JP, Remmelink M, Baan J Jr, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 97(7):990–2, 2006
Konstam MA, Czerska B, Bohm M, et al. continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation 112(20):3107–14, 2005
Lietz K, Miller LW. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol 20(2):132–7, 2005
Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26:1276–83, 2005
Levosimendan
Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202, 2002
De Luca L, Sardella G, Proietti P, et al. Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study. J Am Soc Echocardiogr 19(2):172–7, 2006
Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M; SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883–91, 2007
Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 104(3):556–69, 2006
Ultrafiltration
Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46(11):2043–6, 2005
Continuous Positive Airway Pressure
Bersten AD, Holt AW, Vedig AE, et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 325:1825–30, 1991
Masip J, Betbese AJ, Paez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 356(9248):2126–32, 2000
Therapy
Fonarow GC, Abraham WT, Albert NM, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZEHF): rationale and design. Am Heart J 148(1):43–51, 2004
Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Cardiac Failure 12(1):10–38, 2006
Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46:e1–e82, 2005. Erratum in J Am Coll Cardiol 47:1503–5, 2006
Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Failure 7(3):323–31, 2005
Swedberg K, Cleland J, Dargie H, et al., Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 26:1115–40, 2005
Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 26(4):384–416, 2005
van Meyel JJ, Smits P, Dormans T et al. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med 235:329–34, 1994
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Nieminen, M.S. (2008). Management of Severe Acute Heart Failure. In: Mebazaa, A., Gheorghiade, M., Zannad, F.M., Parrillo, J.E. (eds) Acute Heart Failure. Springer, London. https://doi.org/10.1007/978-1-84628-782-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-84628-782-4_19
Publisher Name: Springer, London
Print ISBN: 978-1-84628-781-7
Online ISBN: 978-1-84628-782-4
eBook Packages: MedicineMedicine (R0)